Guardant Health, Inc.

Historical 13F Holders

Symbol
GH
CUSIP
40131M109
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 40131M109 since 12/18/2024, newest first.

Filer % of Class Filed
Price T Rowe Associates Inc /MD/ 13G/A Amendment 1 4.9% 8/14/2026
Event 6/30/2026
BlackRock, Inc. 13G/A Amendment 3 5.2% 7/28/2026
Event 6/30/2026
Price T Rowe Associates Inc /MD/ 13G 5.4% 5/15/2026
Event 3/31/2026
Vanguard Capital Management LLC 13G 5.0% 4/30/2026
Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 4 0% 3/27/2026
Event 3/13/2026
Deep Track Capital, LP 13G/A Amendment 1
4.4% 5/15/2025
Event 3/31/2025
BlackRock, Inc. 13G/A Amendment 2 7.5% 4/17/2025
Event 3/31/2025
Cadian Capital Management, LP 13G/A Amendment 1
4.2% 2/13/2025
Event 12/31/2024
Wellington Management Group LLP 13G/A Amendment 1
3.9% 2/10/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 19 38.5 k $6.86 M
2026 Q2 630 155 M $20.2 B
2026 Q1 514 135 M $12.5 B
2025 Q4 532 134 M $13.7 B
2025 Q3 429 124 M $7.69 B
2025 Q2 401 126 M $6.52 B
2025 Q1 372 120 M $5.12 B
2024 Q4 327 120 M $3.65 B
2024 Q3 308 128 M $2.87 B
2024 Q2 316 120 M $3.39 B
2024 Q1 301 117 M $2.35 B
2023 Q4 323 117 M $3.09 B
2023 Q3 320 112 M $3.23 B
2023 Q2 327 112 M $3.97 B
2023 Q1 305 92.7 M $2.17 B
2022 Q4 328 95.8 M $2.61 B
2022 Q3 376 95.4 M $5.13 B
2022 Q2 369 93.0 M $3.76 B
2022 Q1 389 93.1 M $6.16 B
2021 Q4 435 92.7 M $9.26 B
2021 Q3 405 94.1 M $11.8 B
2021 Q2 453 89.7 M $11.1 B
2021 Q1 453 91.4 M $13.9 B
2020 Q4 447 87.8 M $11.3 B
2020 Q3 369 85.6 M $9.57 B
2020 Q2 345 84.7 M $6.87 B
2020 Q1 316 80.2 M $5.58 B
2019 Q4 298 77.6 M $6.07 B
2019 Q3 268 74.0 M $4.73 B
2019 Q2 245 76.2 M $6.58 B
2019 Q1 165 60.4 M $4.63 B
2018 Q4 91 61.9 M $2.33 B